Global Bio-based Pentylenediamine Market Growth 2025-2031

December 2025 | 141 pages | ID: G666AF9E3034EN
LP Information

Abstracts

The global Bio-based Pentylenediamine market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.

It is an important C5 platform compound. It is a colorless smoky liquid with a smell similar to ammonia. It is easily soluble in water and ethanol.

United States market for Bio-based Pentylenediamine is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Bio-based Pentylenediamine is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Bio-based Pentylenediamine is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Bio-based Pentylenediamine players cover Cathay Biotech Inc., Aphena Pharma Solutions, Bio-Tech Pharmacal, Goodwin Biotechnology, Xenon Pharmaceuticals, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the “Bio-based Pentylenediamine Industry Forecast” looks at past sales and reviews total world Bio-based Pentylenediamine sales in 2024, providing a comprehensive analysis by region and market sector of projected Bio-based Pentylenediamine sales for 2025 through 2031. With Bio-based Pentylenediamine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Bio-based Pentylenediamine industry.

This Insight Report provides a comprehensive analysis of the global Bio-based Pentylenediamine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Bio-based Pentylenediamine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Bio-based Pentylenediamine market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Bio-based Pentylenediamine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Bio-based Pentylenediamine.

This report presents a comprehensive overview, market shares, and growth opportunities of Bio-based Pentylenediamine market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• Purity Above 99.5%
• Purity Above 99.9%

Segmentation by Application:

• Spinning
• Engineering Materials
• Medicine
• Pesticides
• Organic Synthesis
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• Cathay Biotech Inc.
• Aphena Pharma Solutions
• Bio-Tech Pharmacal
• Goodwin Biotechnology
• Xenon Pharmaceuticals
• Nektar Therapeutics
• Midas Pharmaceuticals
• Kedrion Biopharma
• Xcelthera
• Anichem
• ALC Bio Innovations
• ACADIA Pharmaceuticals
• AbbVie Inc.
• Ology Bioservices
• QMI - Quality Management
• Biomiga
• Molecular Targeting Technologies

Key Questions Addressed in this Report

What is the 10-year outlook for the global Bio-based Pentylenediamine market?

What factors are driving Bio-based Pentylenediamine market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Bio-based Pentylenediamine market opportunities vary by end market size?

How does Bio-based Pentylenediamine break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Bio-based Pentylenediamine Annual Sales 2020-2031
  2.1.2 World Current & Future Analysis for Bio-based Pentylenediamine by Geographic Region, 2020, 2024 & 2031
  2.1.3 World Current & Future Analysis for Bio-based Pentylenediamine by Country/Region, 2020, 2024 & 2031
2.2 Bio-based Pentylenediamine Segment by Type
  2.2.1 Purity Above 99.5%
  2.2.2 Purity Above 99.9%
2.3 Bio-based Pentylenediamine Sales by Type
  2.3.1 Global Bio-based Pentylenediamine Sales Market Share by Type (2020-2025)
  2.3.2 Global Bio-based Pentylenediamine Revenue and Market Share by Type (2020-2025)
  2.3.3 Global Bio-based Pentylenediamine Sale Price by Type (2020-2025)
2.4 Bio-based Pentylenediamine Segment by Application
  2.4.1 Spinning
  2.4.2 Engineering Materials
  2.4.3 Medicine
  2.4.4 Pesticides
  2.4.5 Organic Synthesis
  2.4.6 Others
2.5 Bio-based Pentylenediamine Sales by Application
  2.5.1 Global Bio-based Pentylenediamine Sale Market Share by Application (2020-2025)
  2.5.2 Global Bio-based Pentylenediamine Revenue and Market Share by Application (2020-2025)
  2.5.3 Global Bio-based Pentylenediamine Sale Price by Application (2020-2025)

3 GLOBAL BY COMPANY

3.1 Global Bio-based Pentylenediamine Breakdown Data by Company
  3.1.1 Global Bio-based Pentylenediamine Annual Sales by Company (2020-2025)
  3.1.2 Global Bio-based Pentylenediamine Sales Market Share by Company (2020-2025)
3.2 Global Bio-based Pentylenediamine Annual Revenue by Company (2020-2025)
  3.2.1 Global Bio-based Pentylenediamine Revenue by Company (2020-2025)
  3.2.2 Global Bio-based Pentylenediamine Revenue Market Share by Company (2020-2025)
3.3 Global Bio-based Pentylenediamine Sale Price by Company
3.4 Key Manufacturers Bio-based Pentylenediamine Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Bio-based Pentylenediamine Product Location Distribution
  3.4.2 Players Bio-based Pentylenediamine Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR BIO-BASED PENTYLENEDIAMINE BY GEOGRAPHIC REGION

4.1 World Historic Bio-based Pentylenediamine Market Size by Geographic Region (2020-2025)
  4.1.1 Global Bio-based Pentylenediamine Annual Sales by Geographic Region (2020-2025)
  4.1.2 Global Bio-based Pentylenediamine Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Bio-based Pentylenediamine Market Size by Country/Region (2020-2025)
  4.2.1 Global Bio-based Pentylenediamine Annual Sales by Country/Region (2020-2025)
  4.2.2 Global Bio-based Pentylenediamine Annual Revenue by Country/Region (2020-2025)
4.3 Americas Bio-based Pentylenediamine Sales Growth
4.4 APAC Bio-based Pentylenediamine Sales Growth
4.5 Europe Bio-based Pentylenediamine Sales Growth
4.6 Middle East & Africa Bio-based Pentylenediamine Sales Growth

5 AMERICAS

5.1 Americas Bio-based Pentylenediamine Sales by Country
  5.1.1 Americas Bio-based Pentylenediamine Sales by Country (2020-2025)
  5.1.2 Americas Bio-based Pentylenediamine Revenue by Country (2020-2025)
5.2 Americas Bio-based Pentylenediamine Sales by Type (2020-2025)
5.3 Americas Bio-based Pentylenediamine Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Bio-based Pentylenediamine Sales by Region
  6.1.1 APAC Bio-based Pentylenediamine Sales by Region (2020-2025)
  6.1.2 APAC Bio-based Pentylenediamine Revenue by Region (2020-2025)
6.2 APAC Bio-based Pentylenediamine Sales by Type (2020-2025)
6.3 APAC Bio-based Pentylenediamine Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Bio-based Pentylenediamine by Country
  7.1.1 Europe Bio-based Pentylenediamine Sales by Country (2020-2025)
  7.1.2 Europe Bio-based Pentylenediamine Revenue by Country (2020-2025)
7.2 Europe Bio-based Pentylenediamine Sales by Type (2020-2025)
7.3 Europe Bio-based Pentylenediamine Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Bio-based Pentylenediamine by Country
  8.1.1 Middle East & Africa Bio-based Pentylenediamine Sales by Country (2020-2025)
  8.1.2 Middle East & Africa Bio-based Pentylenediamine Revenue by Country (2020-2025)
8.2 Middle East & Africa Bio-based Pentylenediamine Sales by Type (2020-2025)
8.3 Middle East & Africa Bio-based Pentylenediamine Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Bio-based Pentylenediamine
10.3 Manufacturing Process Analysis of Bio-based Pentylenediamine
10.4 Industry Chain Structure of Bio-based Pentylenediamine

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Bio-based Pentylenediamine Distributors
11.3 Bio-based Pentylenediamine Customer

12 WORLD FORECAST REVIEW FOR BIO-BASED PENTYLENEDIAMINE BY GEOGRAPHIC REGION

12.1 Global Bio-based Pentylenediamine Market Size Forecast by Region
  12.1.1 Global Bio-based Pentylenediamine Forecast by Region (2026-2031)
  12.1.2 Global Bio-based Pentylenediamine Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Bio-based Pentylenediamine Forecast by Type (2026-2031)
12.7 Global Bio-based Pentylenediamine Forecast by Application (2026-2031)

13 KEY PLAYERS ANALYSIS

13.1 Cathay Biotech Inc.
  13.1.1 Cathay Biotech Inc. Company Information
  13.1.2 Cathay Biotech Inc. Bio-based Pentylenediamine Product Portfolios and Specifications
  13.1.3 Cathay Biotech Inc. Bio-based Pentylenediamine Sales, Revenue, Price and Gross Margin (2020-2025)
  13.1.4 Cathay Biotech Inc. Main Business Overview
  13.1.5 Cathay Biotech Inc. Latest Developments
13.2 Aphena Pharma Solutions
  13.2.1 Aphena Pharma Solutions Company Information
  13.2.2 Aphena Pharma Solutions Bio-based Pentylenediamine Product Portfolios and Specifications
  13.2.3 Aphena Pharma Solutions Bio-based Pentylenediamine Sales, Revenue, Price and Gross Margin (2020-2025)
  13.2.4 Aphena Pharma Solutions Main Business Overview
  13.2.5 Aphena Pharma Solutions Latest Developments
13.3 Bio-Tech Pharmacal
  13.3.1 Bio-Tech Pharmacal Company Information
  13.3.2 Bio-Tech Pharmacal Bio-based Pentylenediamine Product Portfolios and Specifications
  13.3.3 Bio-Tech Pharmacal Bio-based Pentylenediamine Sales, Revenue, Price and Gross Margin (2020-2025)
  13.3.4 Bio-Tech Pharmacal Main Business Overview
  13.3.5 Bio-Tech Pharmacal Latest Developments
13.4 Goodwin Biotechnology
  13.4.1 Goodwin Biotechnology Company Information
  13.4.2 Goodwin Biotechnology Bio-based Pentylenediamine Product Portfolios and Specifications
  13.4.3 Goodwin Biotechnology Bio-based Pentylenediamine Sales, Revenue, Price and Gross Margin (2020-2025)
  13.4.4 Goodwin Biotechnology Main Business Overview
  13.4.5 Goodwin Biotechnology Latest Developments
13.5 Xenon Pharmaceuticals
  13.5.1 Xenon Pharmaceuticals Company Information
  13.5.2 Xenon Pharmaceuticals Bio-based Pentylenediamine Product Portfolios and Specifications
  13.5.3 Xenon Pharmaceuticals Bio-based Pentylenediamine Sales, Revenue, Price and Gross Margin (2020-2025)
  13.5.4 Xenon Pharmaceuticals Main Business Overview
  13.5.5 Xenon Pharmaceuticals Latest Developments
13.6 Nektar Therapeutics
  13.6.1 Nektar Therapeutics Company Information
  13.6.2 Nektar Therapeutics Bio-based Pentylenediamine Product Portfolios and Specifications
  13.6.3 Nektar Therapeutics Bio-based Pentylenediamine Sales, Revenue, Price and Gross Margin (2020-2025)
  13.6.4 Nektar Therapeutics Main Business Overview
  13.6.5 Nektar Therapeutics Latest Developments
13.7 Midas Pharmaceuticals
  13.7.1 Midas Pharmaceuticals Company Information
  13.7.2 Midas Pharmaceuticals Bio-based Pentylenediamine Product Portfolios and Specifications
  13.7.3 Midas Pharmaceuticals Bio-based Pentylenediamine Sales, Revenue, Price and Gross Margin (2020-2025)
  13.7.4 Midas Pharmaceuticals Main Business Overview
  13.7.5 Midas Pharmaceuticals Latest Developments
13.8 Kedrion Biopharma
  13.8.1 Kedrion Biopharma Company Information
  13.8.2 Kedrion Biopharma Bio-based Pentylenediamine Product Portfolios and Specifications
  13.8.3 Kedrion Biopharma Bio-based Pentylenediamine Sales, Revenue, Price and Gross Margin (2020-2025)
  13.8.4 Kedrion Biopharma Main Business Overview
  13.8.5 Kedrion Biopharma Latest Developments
13.9 Xcelthera
  13.9.1 Xcelthera Company Information
  13.9.2 Xcelthera Bio-based Pentylenediamine Product Portfolios and Specifications
  13.9.3 Xcelthera Bio-based Pentylenediamine Sales, Revenue, Price and Gross Margin (2020-2025)
  13.9.4 Xcelthera Main Business Overview
  13.9.5 Xcelthera Latest Developments
13.10 Anichem
  13.10.1 Anichem Company Information
  13.10.2 Anichem Bio-based Pentylenediamine Product Portfolios and Specifications
  13.10.3 Anichem Bio-based Pentylenediamine Sales, Revenue, Price and Gross Margin (2020-2025)
  13.10.4 Anichem Main Business Overview
  13.10.5 Anichem Latest Developments
13.11 ALC Bio Innovations
  13.11.1 ALC Bio Innovations Company Information
  13.11.2 ALC Bio Innovations Bio-based Pentylenediamine Product Portfolios and Specifications
  13.11.3 ALC Bio Innovations Bio-based Pentylenediamine Sales, Revenue, Price and Gross Margin (2020-2025)
  13.11.4 ALC Bio Innovations Main Business Overview
  13.11.5 ALC Bio Innovations Latest Developments
13.12 ACADIA Pharmaceuticals
  13.12.1 ACADIA Pharmaceuticals Company Information
  13.12.2 ACADIA Pharmaceuticals Bio-based Pentylenediamine Product Portfolios and Specifications
  13.12.3 ACADIA Pharmaceuticals Bio-based Pentylenediamine Sales, Revenue, Price and Gross Margin (2020-2025)
  13.12.4 ACADIA Pharmaceuticals Main Business Overview
  13.12.5 ACADIA Pharmaceuticals Latest Developments
13.13 AbbVie Inc.
  13.13.1 AbbVie Inc. Company Information
  13.13.2 AbbVie Inc. Bio-based Pentylenediamine Product Portfolios and Specifications
  13.13.3 AbbVie Inc. Bio-based Pentylenediamine Sales, Revenue, Price and Gross Margin (2020-2025)
  13.13.4 AbbVie Inc. Main Business Overview
  13.13.5 AbbVie Inc. Latest Developments
13.14 Ology Bioservices
  13.14.1 Ology Bioservices Company Information
  13.14.2 Ology Bioservices Bio-based Pentylenediamine Product Portfolios and Specifications
  13.14.3 Ology Bioservices Bio-based Pentylenediamine Sales, Revenue, Price and Gross Margin (2020-2025)
  13.14.4 Ology Bioservices Main Business Overview
  13.14.5 Ology Bioservices Latest Developments
13.15 QMI - Quality Management
  13.15.1 QMI - Quality Management Company Information
  13.15.2 QMI - Quality Management Bio-based Pentylenediamine Product Portfolios and Specifications
  13.15.3 QMI - Quality Management Bio-based Pentylenediamine Sales, Revenue, Price and Gross Margin (2020-2025)
  13.15.4 QMI - Quality Management Main Business Overview
  13.15.5 QMI - Quality Management Latest Developments
13.16 Biomiga
  13.16.1 Biomiga Company Information
  13.16.2 Biomiga Bio-based Pentylenediamine Product Portfolios and Specifications
  13.16.3 Biomiga Bio-based Pentylenediamine Sales, Revenue, Price and Gross Margin (2020-2025)
  13.16.4 Biomiga Main Business Overview
  13.16.5 Biomiga Latest Developments
13.17 Molecular Targeting Technologies
  13.17.1 Molecular Targeting Technologies Company Information
  13.17.2 Molecular Targeting Technologies Bio-based Pentylenediamine Product Portfolios and Specifications
  13.17.3 Molecular Targeting Technologies Bio-based Pentylenediamine Sales, Revenue, Price and Gross Margin (2020-2025)
  13.17.4 Molecular Targeting Technologies Main Business Overview
  13.17.5 Molecular Targeting Technologies Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Bio-based Pentylenediamine Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Bio-based Pentylenediamine Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Purity Above 99.5%
Table 4. Major Players of Purity Above 99.9%
Table 5. Global Bio-based Pentylenediamine Sales by Type (2020-2025) & (Tons)
Table 6. Global Bio-based Pentylenediamine Sales Market Share by Type (2020-2025)
Table 7. Global Bio-based Pentylenediamine Revenue by Type (2020-2025) & ($ million)
Table 8. Global Bio-based Pentylenediamine Revenue Market Share by Type (2020-2025)
Table 9. Global Bio-based Pentylenediamine Sale Price by Type (2020-2025) & (US$/Ton)
Table 10. Global Bio-based Pentylenediamine Sale by Application (2020-2025) & (Tons)
Table 11. Global Bio-based Pentylenediamine Sale Market Share by Application (2020-2025)
Table 12. Global Bio-based Pentylenediamine Revenue by Application (2020-2025) & ($ million)
Table 13. Global Bio-based Pentylenediamine Revenue Market Share by Application (2020-2025)
Table 14. Global Bio-based Pentylenediamine Sale Price by Application (2020-2025) & (US$/Ton)
Table 15. Global Bio-based Pentylenediamine Sales by Company (2020-2025) & (Tons)
Table 16. Global Bio-based Pentylenediamine Sales Market Share by Company (2020-2025)
Table 17. Global Bio-based Pentylenediamine Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Bio-based Pentylenediamine Revenue Market Share by Company (2020-2025)
Table 19. Global Bio-based Pentylenediamine Sale Price by Company (2020-2025) & (US$/Ton)
Table 20. Key Manufacturers Bio-based Pentylenediamine Producing Area Distribution and Sales Area
Table 21. Players Bio-based Pentylenediamine Products Offered
Table 22. Bio-based Pentylenediamine Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Bio-based Pentylenediamine Sales by Geographic Region (2020-2025) & (Tons)
Table 26. Global Bio-based Pentylenediamine Sales Market Share Geographic Region (2020-2025)
Table 27. Global Bio-based Pentylenediamine Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Bio-based Pentylenediamine Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Bio-based Pentylenediamine Sales by Country/Region (2020-2025) & (Tons)
Table 30. Global Bio-based Pentylenediamine Sales Market Share by Country/Region (2020-2025)
Table 31. Global Bio-based Pentylenediamine Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Bio-based Pentylenediamine Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Bio-based Pentylenediamine Sales by Country (2020-2025) & (Tons)
Table 34. Americas Bio-based Pentylenediamine Sales Market Share by Country (2020-2025)
Table 35. Americas Bio-based Pentylenediamine Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Bio-based Pentylenediamine Sales by Type (2020-2025) & (Tons)
Table 37. Americas Bio-based Pentylenediamine Sales by Application (2020-2025) & (Tons)
Table 38. APAC Bio-based Pentylenediamine Sales by Region (2020-2025) & (Tons)
Table 39. APAC Bio-based Pentylenediamine Sales Market Share by Region (2020-2025)
Table 40. APAC Bio-based Pentylenediamine Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Bio-based Pentylenediamine Sales by Type (2020-2025) & (Tons)
Table 42. APAC Bio-based Pentylenediamine Sales by Application (2020-2025) & (Tons)
Table 43. Europe Bio-based Pentylenediamine Sales by Country (2020-2025) & (Tons)
Table 44. Europe Bio-based Pentylenediamine Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Bio-based Pentylenediamine Sales by Type (2020-2025) & (Tons)
Table 46. Europe Bio-based Pentylenediamine Sales by Application (2020-2025) & (Tons)
Table 47. Middle East & Africa Bio-based Pentylenediamine Sales by Country (2020-2025) & (Tons)
Table 48. Middle East & Africa Bio-based Pentylenediamine Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Bio-based Pentylenediamine Sales by Type (2020-2025) & (Tons)
Table 50. Middle East & Africa Bio-based Pentylenediamine Sales by Application (2020-2025) & (Tons)
Table 51. Key Market Drivers & Growth Opportunities of Bio-based Pentylenediamine
Table 52. Key Market Challenges & Risks of Bio-based Pentylenediamine
Table 53. Key Industry Trends of Bio-based Pentylenediamine
Table 54. Bio-based Pentylenediamine Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Bio-based Pentylenediamine Distributors List
Table 57. Bio-based Pentylenediamine Customer List
Table 58. Global Bio-based Pentylenediamine Sales Forecast by Region (2026-2031) & (Tons)
Table 59. Global Bio-based Pentylenediamine Revenue Forecast by Region (2026-2031) & ($ millions)
Table 60. Americas Bio-based Pentylenediamine Sales Forecast by Country (2026-2031) & (Tons)
Table 61. Americas Bio-based Pentylenediamine Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 62. APAC Bio-based Pentylenediamine Sales Forecast by Region (2026-2031) & (Tons)
Table 63. APAC Bio-based Pentylenediamine Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Europe Bio-based Pentylenediamine Sales Forecast by Country (2026-2031) & (Tons)
Table 65. Europe Bio-based Pentylenediamine Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Bio-based Pentylenediamine Sales Forecast by Country (2026-2031) & (Tons)
Table 67. Middle East & Africa Bio-based Pentylenediamine Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Global Bio-based Pentylenediamine Sales Forecast by Type (2026-2031) & (Tons)
Table 69. Global Bio-based Pentylenediamine Revenue Forecast by Type (2026-2031) & ($ millions)
Table 70. Global Bio-based Pentylenediamine Sales Forecast by Application (2026-2031) & (Tons)
Table 71. Global Bio-based Pentylenediamine Revenue Forecast by Application (2026-2031) & ($ millions)
Table 72. Cathay Biotech Inc. Basic Information, Bio-based Pentylenediamine Manufacturing Base, Sales Area and Its Competitors
Table 73. Cathay Biotech Inc. Bio-based Pentylenediamine Product Portfolios and Specifications
Table 74. Cathay Biotech Inc. Bio-based Pentylenediamine Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 75. Cathay Biotech Inc. Main Business
Table 76. Cathay Biotech Inc. Latest Developments
Table 77. Aphena Pharma Solutions Basic Information, Bio-based Pentylenediamine Manufacturing Base, Sales Area and Its Competitors
Table 78. Aphena Pharma Solutions Bio-based Pentylenediamine Product Portfolios and Specifications
Table 79. Aphena Pharma Solutions Bio-based Pentylenediamine Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 80. Aphena Pharma Solutions Main Business
Table 81. Aphena Pharma Solutions Latest Developments
Table 82. Bio-Tech Pharmacal Basic Information, Bio-based Pentylenediamine Manufacturing Base, Sales Area and Its Competitors
Table 83. Bio-Tech Pharmacal Bio-based Pentylenediamine Product Portfolios and Specifications
Table 84. Bio-Tech Pharmacal Bio-based Pentylenediamine Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 85. Bio-Tech Pharmacal Main Business
Table 86. Bio-Tech Pharmacal Latest Developments
Table 87. Goodwin Biotechnology Basic Information, Bio-based Pentylenediamine Manufacturing Base, Sales Area and Its Competitors
Table 88. Goodwin Biotechnology Bio-based Pentylenediamine Product Portfolios and Specifications
Table 89. Goodwin Biotechnology Bio-based Pentylenediamine Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 90. Goodwin Biotechnology Main Business
Table 91. Goodwin Biotechnology Latest Developments
Table 92. Xenon Pharmaceuticals Basic Information, Bio-based Pentylenediamine Manufacturing Base, Sales Area and Its Competitors
Table 93. Xenon Pharmaceuticals Bio-based Pentylenediamine Product Portfolios and Specifications
Table 94. Xenon Pharmaceuticals Bio-based Pentylenediamine Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 95. Xenon Pharmaceuticals Main Business
Table 96. Xenon Pharmaceuticals Latest Developments
Table 97. Nektar Therapeutics Basic Information, Bio-based Pentylenediamine Manufacturing Base, Sales Area and Its Competitors
Table 98. Nektar Therapeutics Bio-based Pentylenediamine Product Portfolios and Specifications
Table 99. Nektar Therapeutics Bio-based Pentylenediamine Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 100. Nektar Therapeutics Main Business
Table 101. Nektar Therapeutics Latest Developments
Table 102. Midas Pharmaceuticals Basic Information, Bio-based Pentylenediamine Manufacturing Base, Sales Area and Its Competitors
Table 103. Midas Pharmaceuticals Bio-based Pentylenediamine Product Portfolios and Specifications
Table 104. Midas Pharmaceuticals Bio-based Pentylenediamine Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 105. Midas Pharmaceuticals Main Business
Table 106. Midas Pharmaceuticals Latest Developments
Table 107. Kedrion Biopharma Basic Information, Bio-based Pentylenediamine Manufacturing Base, Sales Area and Its Competitors
Table 108. Kedrion Biopharma Bio-based Pentylenediamine Product Portfolios and Specifications
Table 109. Kedrion Biopharma Bio-based Pentylenediamine Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 110. Kedrion Biopharma Main Business
Table 111. Kedrion Biopharma Latest Developments
Table 112. Xcelthera Basic Information, Bio-based Pentylenediamine Manufacturing Base, Sales Area and Its Competitors
Table 113. Xcelthera Bio-based Pentylenediamine Product Portfolios and Specifications
Table 114. Xcelthera Bio-based Pentylenediamine Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 115. Xcelthera Main Business
Table 116. Xcelthera Latest Developments
Table 117. Anichem Basic Information, Bio-based Pentylenediamine Manufacturing Base, Sales Area and Its Competitors
Table 118. Anichem Bio-based Pentylenediamine Product Portfolios and Specifications
Table 119. Anichem Bio-based Pentylenediamine Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 120. Anichem Main Business
Table 121. Anichem Latest Developments
Table 122. ALC Bio Innovations Basic Information, Bio-based Pentylenediamine Manufacturing Base, Sales Area and Its Competitors
Table 123. ALC Bio Innovations Bio-based Pentylenediamine Product Portfolios and Specifications
Table 124. ALC Bio Innovations Bio-based Pentylenediamine Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 125. ALC Bio Innovations Main Business
Table 126. ALC Bio Innovations Latest Developments
Table 127. ACADIA Pharmaceuticals Basic Information, Bio-based Pentylenediamine Manufacturing Base, Sales Area and Its Competitors
Table 128. ACADIA Pharmaceuticals Bio-based Pentylenediamine Product Portfolios and Specifications
Table 129. ACADIA Pharmaceuticals Bio-based Pentylenediamine Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 130. ACADIA Pharmaceuticals Main Business
Table 131. ACADIA Pharmaceuticals Latest Developments
Table 132. AbbVie Inc. Basic Information, Bio-based Pentylenediamine Manufacturing Base, Sales Area and Its Competitors
Table 133. AbbVie Inc. Bio-based Pentylenediamine Product Portfolios and Specifications
Table 134. AbbVie Inc. Bio-based Pentylenediamine Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 135. AbbVie Inc. Main Business
Table 136. AbbVie Inc. Latest Developments
Table 137. Ology Bioservices Basic Information, Bio-based Pentylenediamine Manufacturing Base, Sales Area and Its Competitors
Table 138. Ology Bioservices Bio-based Pentylenediamine Product Portfolios and Specifications
Table 139. Ology Bioservices Bio-based Pentylenediamine Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 140. Ology Bioservices Main Business
Table 141. Ology Bioservices Latest Developments
Table 142. QMI - Quality Management Basic Information, Bio-based Pentylenediamine Manufacturing Base, Sales Area and Its Competitors
Table 143. QMI - Quality Management Bio-based Pentylenediamine Product Portfolios and Specifications
Table 144. QMI - Quality Management Bio-based Pentylenediamine Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 145. QMI - Quality Management Main Business
Table 146. QMI - Quality Management Latest Developments
Table 147. Biomiga Basic Information, Bio-based Pentylenediamine Manufacturing Base, Sales Area and Its Competitors
Table 148. Biomiga Bio-based Pentylenediamine Product Portfolios and Specifications
Table 149. Biomiga Bio-based Pentylenediamine Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 150. Biomiga Main Business
Table 151. Biomiga Latest Developments
Table 152. Molecular Targeting Technologies Basic Information, Bio-based Pentylenediamine Manufacturing Base, Sales Area and Its Competitors
Table 153. Molecular Targeting Technologies Bio-based Pentylenediamine Product Portfolios and Specifications
Table 154. Molecular Targeting Technologies Bio-based Pentylenediamine Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 155. Molecular Targeting Technologies Main Business
Table 156. Molecular Targeting Technologies Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Bio-based Pentylenediamine
Figure 2. Bio-based Pentylenediamine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Bio-based Pentylenediamine Sales Growth Rate 2020-2031 (Tons)
Figure 7. Global Bio-based Pentylenediamine Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Bio-based Pentylenediamine Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Bio-based Pentylenediamine Sales Market Share by Country/Region (2024)
Figure 10. Bio-based Pentylenediamine Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Purity Above 99.5%
Figure 12. Product Picture of Purity Above 99.9%
Figure 13. Global Bio-based Pentylenediamine Sales Market Share by Type in 2025
Figure 14. Global Bio-based Pentylenediamine Revenue Market Share by Type (2020-2025)
Figure 15. Bio-based Pentylenediamine Consumed in Spinning
Figure 16. Global Bio-based Pentylenediamine Market: Spinning (2020-2025) & (Tons)
Figure 17. Bio-based Pentylenediamine Consumed in Engineering Materials
Figure 18. Global Bio-based Pentylenediamine Market: Engineering Materials (2020-2025) & (Tons)
Figure 19. Bio-based Pentylenediamine Consumed in Medicine
Figure 20. Global Bio-based Pentylenediamine Market: Medicine (2020-2025) & (Tons)
Figure 21. Bio-based Pentylenediamine Consumed in Pesticides
Figure 22. Global Bio-based Pentylenediamine Market: Pesticides (2020-2025) & (Tons)
Figure 23. Bio-based Pentylenediamine Consumed in Organic Synthesis
Figure 24. Global Bio-based Pentylenediamine Market: Organic Synthesis (2020-2025) & (Tons)
Figure 25. Bio-based Pentylenediamine Consumed in Others
Figure 26. Global Bio-based Pentylenediamine Market: Others (2020-2025) & (Tons)
Figure 27. Global Bio-based Pentylenediamine Sale Market Share by Application (2024)
Figure 28. Global Bio-based Pentylenediamine Revenue Market Share by Application in 2025
Figure 29. Bio-based Pentylenediamine Sales by Company in 2025 (Tons)
Figure 30. Global Bio-based Pentylenediamine Sales Market Share by Company in 2025
Figure 31. Bio-based Pentylenediamine Revenue by Company in 2025 ($ millions)
Figure 32. Global Bio-based Pentylenediamine Revenue Market Share by Company in 2025
Figure 33. Global Bio-based Pentylenediamine Sales Market Share by Geographic Region (2020-2025)
Figure 34. Global Bio-based Pentylenediamine Revenue Market Share by Geographic Region in 2025
Figure 35. Americas Bio-based Pentylenediamine Sales 2020-2025 (Tons)
Figure 36. Americas Bio-based Pentylenediamine Revenue 2020-2025 ($ millions)
Figure 37. APAC Bio-based Pentylenediamine Sales 2020-2025 (Tons)
Figure 38. APAC Bio-based Pentylenediamine Revenue 2020-2025 ($ millions)
Figure 39. Europe Bio-based Pentylenediamine Sales 2020-2025 (Tons)
Figure 40. Europe Bio-based Pentylenediamine Revenue 2020-2025 ($ millions)
Figure 41. Middle East & Africa Bio-based Pentylenediamine Sales 2020-2025 (Tons)
Figure 42. Middle East & Africa Bio-based Pentylenediamine Revenue 2020-2025 ($ millions)
Figure 43. Americas Bio-based Pentylenediamine Sales Market Share by Country in 2025
Figure 44. Americas Bio-based Pentylenediamine Revenue Market Share by Country (2020-2025)
Figure 45. Americas Bio-based Pentylenediamine Sales Market Share by Type (2020-2025)
Figure 46. Americas Bio-based Pentylenediamine Sales Market Share by Application (2020-2025)
Figure 47. United States Bio-based Pentylenediamine Revenue Growth 2020-2025 ($ millions)
Figure 48. Canada Bio-based Pentylenediamine Revenue Growth 2020-2025 ($ millions)
Figure 49. Mexico Bio-based Pentylenediamine Revenue Growth 2020-2025 ($ millions)
Figure 50. Brazil Bio-based Pentylenediamine Revenue Growth 2020-2025 ($ millions)
Figure 51. APAC Bio-based Pentylenediamine Sales Market Share by Region in 2025
Figure 52. APAC Bio-based Pentylenediamine Revenue Market Share by Region (2020-2025)
Figure 53. APAC Bio-based Pentylenediamine Sales Market Share by Type (2020-2025)
Figure 54. APAC Bio-based Pentylenediamine Sales Market Share by Application (2020-2025)
Figure 55. China Bio-based Pentylenediamine Revenue Growth 2020-2025 ($ millions)
Figure 56. Japan Bio-based Pentylenediamine Revenue Growth 2020-2025 ($ millions)
Figure 57. South Korea Bio-based Pentylenediamine Revenue Growth 2020-2025 ($ millions)
Figure 58. Southeast Asia Bio-based Pentylenediamine Revenue Growth 2020-2025 ($ millions)
Figure 59. India Bio-based Pentylenediamine Revenue Growth 2020-2025 ($ millions)
Figure 60. Australia Bio-based Pentylenediamine Revenue Growth 2020-2025 ($ millions)
Figure 61. China Taiwan Bio-based Pentylenediamine Revenue Growth 2020-2025 ($ millions)
Figure 62. Europe Bio-based Pentylenediamine Sales Market Share by Country in 2025
Figure 63. Europe Bio-based Pentylenediamine Revenue Market Share by Country (2020-2025)
Figure 64. Europe Bio-based Pentylenediamine Sales Market Share by Type (2020-2025)
Figure 65. Europe Bio-based Pentylenediamine Sales Market Share by Application (2020-2025)
Figure 66. Germany Bio-based Pentylenediamine Revenue Growth 2020-2025 ($ millions)
Figure 67. France Bio-based Pentylenediamine Revenue Growth 2020-2025 ($ millions)
Figure 68. UK Bio-based Pentylenediamine Revenue Growth 2020-2025 ($ millions)
Figure 69. Italy Bio-based Pentylenediamine Revenue Growth 2020-2025 ($ millions)
Figure 70. Russia Bio-based Pentylenediamine Revenue Growth 2020-2025 ($ millions)
Figure 71. Middle East & Africa Bio-based Pentylenediamine Sales Market Share by Country (2020-2025)
Figure 72. Middle East & Africa Bio-based Pentylenediamine Sales Market Share by Type (2020-2025)
Figure 73. Middle East & Africa Bio-based Pentylenediamine Sales Market Share by Application (2020-2025)
Figure 74. Egypt Bio-based Pentylenediamine Revenue Growth 2020-2025 ($ millions)
Figure 75. South Africa Bio-based Pentylenediamine Revenue Growth 2020-2025 ($ millions)
Figure 76. Israel Bio-based Pentylenediamine Revenue Growth 2020-2025 ($ millions)
Figure 77. Turkey Bio-based Pentylenediamine Revenue Growth 2020-2025 ($ millions)
Figure 78. GCC Countries Bio-based Pentylenediamine Revenue Growth 2020-2025 ($ millions)
Figure 79. Manufacturing Cost Structure Analysis of Bio-based Pentylenediamine in 2025
Figure 80. Manufacturing Process Analysis of Bio-based Pentylenediamine
Figure 81. Industry Chain Structure of Bio-based Pentylenediamine
Figure 82. Channels of Distribution
Figure 83. Global Bio-based Pentylenediamine Sales Market Forecast by Region (2026-2031)
Figure 84. Global Bio-based Pentylenediamine Revenue Market Share Forecast by Region (2026-2031)
Figure 85. Global Bio-based Pentylenediamine Sales Market Share Forecast by Type (2026-2031)
Figure 86. Global Bio-based Pentylenediamine Revenue Market Share Forecast by Type (2026-2031)
Figure 87. Global Bio-based Pentylenediamine Sales Market Share Forecast by Application (2026-2031)
Figure 88. Global Bio-based Pentylenediamine Revenue Market Share Forecast by Application (2026-2031)